Company & Sponsor Intelligence
University of Vermont
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials1
Recruiting0
Completed0
Countries1
Therapeutic footprint
parkinsons
Indexed studies
NCT02529397Obesity Treatment Enhanced With Working Memory Training
adhd · United StatesNA
adhd · United StatesNA
NCT01216904Nicotine Treatment of Impulsivity in Parkinson's Disease
parkinsons · United StatesPHASE4
parkinsons · United StatesPHASE4
Intelligence layer updated: 2026-06-10 02:57:56.223123+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →